| | |
Filomena Leonardi, Sachin Rajan and Claudia Schütz 09:42 PM | September 23,2009
Drug makers must be able to define strategies and execute them flawlessly
|
|
Reuters 12:13 PM | September 14,2009
Dr Reddy’s and local rivals such as Ranbaxy Laboratories Ltd and Cipla Ltd have thrived on booming global demand for generic drugs as nations around the world battle rising healthcare costs
|
|
Radhieka Pandeya 11:47 PM | June 15,2009
The Jan Aushadhi programme aims at opening medicine shops across the country at government hospitals and other places that would either be state-run or operated by non-profit organizations
|
|
Tiisetso Motsoeneng and Ben Hirschler / Reuters 05:23 PM | March 25,2009
Deal to strengthen partnership between drug companies; Glaxo sees Aspen as springboard into emerging markets
|
|
Ajay Bhatnagar 09:45 PM | January 18,2009
New drugs discovered by using advances in the molecular basis of disease require different methods of evaluation. Their use as generics is unlikely to work
|
|
Kanoko Matsuyama / Bloomberg 11:20 PM | January 15,2009
The company was purchased by Daiichi Sankyo Co., Japan’s third largest drug maker, last year
|
|
PTI 07:10 PM | January 07,2009
These products -- both generic and branded verions -- all together have annualised sales of more than $650 million in the US
|
|
C.H. Unnikrishnan 08:44 PM | November 02,2008
Buying back shares from the open market at a premium could help support the stock in a bear run
|
|
Lison Joseph 12:13 AM | October 24,2008
Net profit for the quarter stood at Rs121 crore, or 8% of the company’s revenues, compared with Rs252.70 crore, or 20% of the revenues in the year-ago period
|
|
02:10 PM | October 13,2008
The state government would provide logistics for the opening of these stores to make available drugs at cheaper rates on mass scale
|
|
02:49 PM | September 17,2008
The Food and Drug Administration has issued two warning letters to the company and an import alert for generic drugs produced by two of its plants
|
|
Lison Joseph 12:22 AM | September 11,2008
The firm will revamp its business model to beat competitive pressures in generic drug manufacturing
|
|
C.H. Unnikrishnan and Baiju Kalesh 11:14 PM | August 06,2008
Mylan and Famy Care will invest almost equally in the product development and marketing partnership, and share the profits
|
|
12:16 PM | April 30,2008
Post-acquisition, Dr Reddy’s will be making generic prescription and OTC products for branded and generic companies in the US
|
|
AFP 01:57 PM | February 28,2008
Many activists have complained that the cost of patented drugs is too high and that provision should be made to allow generic drugs to be supplied to the country’s legion of poor
|
|